- Share via
Founded in 2010, Onyx Healthcare has evolved from a provider of medical-grade computing platforms into a global MedTech partner serving leading medical device companies worldwide. Today, the company develops medical AI computing systems, AI servers, smart healthcare workflow solutions, and contract manufacturing services, positioning itself at the intersection of healthcare and advanced technology.
Central to that strategy is a strong focus on three high-growth areas: imaging AI, medical and surgical robotics, and remote patient monitoring AI. Rather than replacing clinicians, these technologies are designed to enhance decision-making and improve efficiency in increasingly resource-constrained healthcare environments.
“Assistive AI is really the key,” said John Chuang, President of Onyx Healthcare. “Doctors are adopting technologies that help them save time and serve more patients.”
The company’s growing role within the global AI ecosystem is strengthened through collaborations with industry leaders including NVIDIA, Intel and Qualcomm. From AI-powered medical imaging solutions to rehabilitation robotics and patient monitoring edge AI applications, these partnerships are helping accelerate the deployment of next-generation healthcare technologies.
International expansion remains a core priority. The United States is now Onyx’s largest market, driven by strong demand from medical device OEM and ODM customers. To support long-term growth, the company has established its U.S. operations as its global headquarters and developed Made-in-USA manufacturing capabilities alongside its manufacturing base in Taiwan.
This dual-market approach reflects a broader vision: combining Taiwan’s technology strengths with proximity to the world’s largest healthcare market.
At the same time, Onyx is positioning itself as a “MedTech foundry,” providing the technology, manufacturing expertise, and regulatory capabilities required to help healthcare innovators bring new products to market. With FDA registration, ISO 13485 certification, and GMP/QMS advanced manufacturing quality management systems, the company aims to serve as a trusted partner for medical device companies worldwide.
As healthcare systems confront workforce shortages, aging populations, and rising demand for efficiency, the adoption of medical AI continues to accelerate. Against this backdrop, Onyx sees significant opportunities not only for its own growth but also for Taiwan’s Smart Healthcare sector as a whole.
“Taiwan is at the front and center of the technology wave,” said Chuang. “As AI continues to evolve, it makes perfect sense to collaborate with Taiwan’s industry to successfully deploy innovation and healthcare technologies worldwide.”
